PT Nanotech Indonesia Global Tbk (IDX:NANO)
Indonesia · Delayed Price · Currency is IDR 74.00
+6.00 (8.82%)
Sep 4, 2025, 4:11 PM WIB
IDX:NANO Revenue
PT Nanotech Indonesia Global Tbk had revenue of 52.49B IDR in the half year ending June 30, 2025, with 133.59% growth. This brings the company's revenue in the last twelve months to 118.29B, up 7.14% year-over-year. In the year 2024, PT Nanotech Indonesia Global Tbk had annual revenue of 114.86B with 37.03% growth.
Revenue (ttm)
118.29B
Revenue Growth
+7.14%
P/S Ratio
2.68
Revenue / Employee
6.57B
Employees
18
Market Cap
317.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114.86B | 31.04B | 37.03% |
| Dec 31, 2023 | 83.82B | 39.12B | 87.50% |
| Dec 31, 2022 | 44.70B | 17.93B | 66.97% |
| Dec 31, 2021 | 26.77B | 10.73B | 66.92% |
| Dec 31, 2020 | 16.04B | 7.97B | 98.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 3,202.64B |
| PT Kalbe Farma Tbk. | 33.38T |
| PT Mitra Keluarga Karyasehat Tbk | 4,985.33B |
| PT Siloam International Hospitals Tbk | 12.30T |
| PT Medikaloka Hermina Tbk | 6,761.48B |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3,851.30B |
| PT Tempo Scan Pacific Tbk | 13.48T |
| PT Metro Healthcare Indonesia Tbk | 311.61B |